AR022955A1 - Solucion de ibuprofen - Google Patents

Solucion de ibuprofen

Info

Publication number
AR022955A1
AR022955A1 ARP000101171A ARP000101171A AR022955A1 AR 022955 A1 AR022955 A1 AR 022955A1 AR P000101171 A ARP000101171 A AR P000101171A AR P000101171 A ARP000101171 A AR P000101171A AR 022955 A1 AR022955 A1 AR 022955A1
Authority
AR
Argentina
Prior art keywords
ibuprofen solution
ibuprofen
solution
medicament
aqueous solution
Prior art date
Application number
ARP000101171A
Other languages
English (en)
Original Assignee
Merckle Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merckle Gmbh filed Critical Merckle Gmbh
Publication of AR022955A1 publication Critical patent/AR022955A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

La invencion se refiere a una solucion acuosa de Ibuprofen que es adecuada como medicamento, en especial para infusiones intravenosas.
ARP000101171A 1999-03-19 2000-03-16 Solucion de ibuprofen AR022955A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19912436A DE19912436A1 (de) 1999-03-19 1999-03-19 Ibuprofen-Lösung

Publications (1)

Publication Number Publication Date
AR022955A1 true AR022955A1 (es) 2002-09-04

Family

ID=7901665

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000101171A AR022955A1 (es) 1999-03-19 2000-03-16 Solucion de ibuprofen

Country Status (4)

Country Link
AR (1) AR022955A1 (es)
AU (1) AU4106000A (es)
DE (1) DE19912436A1 (es)
WO (1) WO2000056325A2 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10240418A1 (de) * 2002-09-02 2004-03-11 Avontec Gmbh Formulierung zur Einschleusung von Nukleinsäuren in eukaryotische Zellen
ES2823249T3 (es) * 2009-03-12 2021-05-06 Cumberland Pharmaceuticals Inc Administración de ibuprofeno por vía intravenosa
US8871810B2 (en) 2009-07-15 2014-10-28 Cumberland Pharmaceuticals Inc. Treating critically ill patients with intravenous ibuprofen
WO2011144766A1 (es) * 2010-05-18 2011-11-24 Spain Pharma, S.A. Composición farmacéutica de ibuprofeno para inyección
US9072710B2 (en) 2012-03-16 2015-07-07 Cumberland Pharmaceuticals Inc. Injectable ibuprofen formulation
CN104323988A (zh) * 2014-11-27 2015-02-04 北京蓝丹医药科技有限公司 一种用于注射的右旋布洛芬药物组合物
CN105055389B (zh) * 2015-08-03 2018-08-10 北京蓝丹医药科技有限公司 一种用于早产儿先天性心脏病的布洛芬药物组合物
CN105997901A (zh) * 2016-07-27 2016-10-12 济南东方开元医药新技术有限公司 小儿注射用布洛芬氨丁三醇冻干粉针组合物及制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU185926B (en) * 1979-09-27 1985-04-28 Agostne Kahan Process for preparing water soluble derivatives of non-steroid antiinflammatory compositions and pharmaceutical compositins containing such derivatives
ZA959469B (en) * 1994-11-15 1996-05-15 South African Druggists Ltd Pharmaceutical composition
ATE265847T1 (de) * 1997-07-29 2004-05-15 Upjohn Co Selbstemulgierbare formulierung enthaltend lipophile verbindungen

Also Published As

Publication number Publication date
WO2000056325A2 (de) 2000-09-28
WO2000056325A3 (de) 2000-12-28
AU4106000A (en) 2000-10-09
DE19912436A1 (de) 2000-09-21

Similar Documents

Publication Publication Date Title
HN2001000224A (es) Compuestos de imidazol condensado con arilo o heteroarilo como agentes anti - inflamatorios y analgesicos.
EA200400481A1 (ru) Применение флибансерина для лечения половых расстройств
GT200000158A (es) Piridinas y piridacinas sustituidas con actividad de inhibicion de angiogenesis.
CR6895A (es) Nuevos compuestos heterociclicos su preparacion y su utilizacion como medicamentos en especial como antibacterianos
CY1112361T1 (el) Σκευασματα για αντικαρκινικη θεραπεια που περιεχουν εκτεϊνασκιδινη 743
UY26496A1 (es) Composiciones farmacéuticas que proporcionan concentraciones potenciadas de fármaco
BR0015188A (pt) Composições farmacêuticas
EA200101046A1 (ru) Производные индигоидных бис-индолов
ECSP066662A (es) Preparación farmacéutica que comprende un anticuerpo contra el receptor egf
PE20050469A1 (es) Modulacion de la expresion de eif4e
HN1999000124A (es) Derivados de pirazol substituido.
HN1999000125A (es) Nuevos derivados sustituidos del pirazol
AR033423A1 (es) Sales farmaceuticas constituidas de una sustancia activa farmaceutica y al menos un edulcorante, medicamentos que contienen estas sales y uso de estas sales para la preparacion de medicamentos
HN2008001103A (es) Agentes citotoxicos que comprenden nuevos derivados de tomaimicina
UY25055A1 (es) Formulaciones farmacéuticas que contienen voriconazol
AR058433A1 (es) Derivado de 1,1-dioxido de 1,4-benzotiazepina ,procedimiento para su preparacion ,medicamentos que comprenden este compuesto y su uso
HN2000000267A (es) Oxazolidinonas substituidas y su uso
PA8514401A1 (es) Nuevos derivados de piperazina
PA8586201A1 (es) Nuevas formulaciones de liberacion prolongada inyectables
ECSP056071A (es) Nueva difenilazetidinona con características fisiológicas mejoradas, correspondiente método de producción, medicamentos que contienen dicho compuesto y su uso
HN2002000300A (es) Nuevos derivados de piperazina
AR012504A1 (es) Utilizacion de derivados de tetrahidropiridina, para la preparacion de medicamentos para el tratamiento de las enfermedades que provocan unadesmielinizacion.
AR025052A1 (es) Derivados de 2-dialquilaminoalquilbifenilo sustituidos, procedimiento para su preparacion, medicamentos que contienen estos compuestos y el uso de estoscompuestos para la preparacion de medicamentos.
AR022955A1 (es) Solucion de ibuprofen
SE9901077D0 (sv) Novel use